EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazza, F.
Right arrow Articles by Abraham, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazza, F.
Right arrow Articles by Abraham, N. G.
Experimental Biology and Medicine 228:576-583 (2003)
© 2003 Society for Experimental Biology and Medicine


HEME OXYGENASE

Heme Oxygenase-1 Gene Expression Attenuates Angiotensin II-Mediated DNA Damage in Endothelial Cells

Francesco Mazza*, Alvin Goodman{ddagger}, Gabriella Lombardo{dagger}, Angelo Vanella* and Nader G. Abraham{dagger},1

{ddagger} Department of Medicine and
{dagger} Pharmacology, New York Medical College, Valhalla, New York And
* Department of Biological Chemistry, School of Pharmacy, University of Catania, Catania, Italy

Abstract

Heme oxygenase (HO) catalyzes the conversion of heme to biliverdin with the release of iron and carbon monoxide. HO-1 is inducible by inflammatory conditions, which cause oxidative stress in endothelial cells. Overexpression of human HO-1 in endothelial cells may have the potential to provide protection against a variety of agents that cause oxidative stress. We investigated the physiological significance of human HO-1 overexpression using a retroviral vector on attenuation of angiotensin II (Ang II)-mediated oxidative stress. Comet and glutathione (GSH) levels were used as indicators of the levels of oxidative stress. Comet assay was performed to evaluate damage on DNA, whereas GSH levels were measured to determine the unbalance of redox potential. Pretreatments with inducers, such as heme 10 µM, SnCl2 10 µM, and inhibitors, such as tin-mesoporphyrin 10 µM was followed by treatment with Ang II 200 ng/ml. Pretreatment with heme or SnCl2 provoked significant reductions (P < 0.01) of tail moment in the comet assay. Opposite effects were evident by pretreatment for 16 hr with tin-mesoporphyrin. A decrease in tail moment levels was found in human endothelial cells transduced with the human HO-1 gene. The addition of Ang II (200 ng/ml) to human dermal microvessel endothelial cel1-1 for 16 hr resulted in a significant (P < 0.05) reduction of GSH contents control endothelial cells but not in endothelial cells transduced with HO-1 gene. The results presented indicated that stimulation or overexpression of HO-1 attenuated DNA damages caused by exposures of Ang II.

Key Words: oxidative stress • cell cycle • antioxidant • reactive oxygen species • cell cycle inhibitor




This article has been cited by other articles:


Home page
IOVSHome page
M.-H. Sun, J.-H. S. Pang, S.-L. Chen, P.-C. Kuo, K.-J. Chen, L.-Y. Kao, J.-Y. Wu, K.-K. Lin, and Y.-P. Tsao
Photoreceptor Protection against Light Damage by AAV-Mediated Overexpression of Heme Oxygenase-1
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5699 - 5707.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Schupp, U. Schmid, P. Rutkowski, U. Lakner, N. Kanase, A. Heidland, and H. Stopper
Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1427 - F1434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Vera, S. Kelsen, L. L. Yanes, J. F. Reckelhoff, and D. E. Stec
HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1472 - R1478.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes, I. Fleming, and R. Busse
Endothelial aging
Cardiovasc Res, May 1, 2005; 66(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller, G. Li Volti, A. I. Goodman, and A. Kappas
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2468 - H2477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Martin, A. I. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, C. M. R. de Galarreta, and A. Cuadrado
Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol
J. Biol. Chem., March 5, 2004; 279(10): 8919 - 8929.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. M. Sikorski, T. Hock, N. Hill-Kapturczak, and A. Agarwal
The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F425 - F441.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ritz and V. Haxsen
Angiotensin II and Oxidative Stress: An Unholy Alliance
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2985 - 2987.
[Full Text] [PDF]


Home page
Circ. Res.Home page
N. G. Abraham, T. Kushida, J. McClung, M. Weiss, S. Quan, R. Lafaro, Z. Darzynkiewicz, and M. Wolin
Heme Oxygenase-1 Attenuates Glucose-Mediated Cell Growth Arrest and Apoptosis in Human Microvessel Endothelial Cells
Circ. Res., September 19, 2003; 93(6): 507 - 514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Experimental Biology and Medicine.